BRCA1 and Fanconi anemia: Zhang et al. have shown that after the cells are treated with THZ531 (CDK12 inhibitor), the expression of core DDR genes (BRCA1, FANCF (Fanconi anemia complementation group F) and ERCC4 (excision repair cross-complementing group 4)) is decreased [12].